Prapassorn Thirasastr

5PUBLICATIONS
31CO-AUTHORS
Evolutionary ecologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

|Mar 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?

Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph

|Feb 17, 2023
Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors.

Prapassorn Thirasastr, Neeta Somaiah

|Sep 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.

Prapassorn Thirasastr, Heather Lin, Behrang Amini

|Mar 07, 2022
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma.

Prapassorn Thirasastr, Neeta Somaiah

Pageof 1

Frequent Collaborators

3 joint publications

Neeta Somaiah

2 joint publications

Elise F Nassif Haddad

1 joint publications

Behrang Amini

1 joint publications

Emily Z Keung